San Diego, CA - December 8, 2021 (Investorideas.com Newswire) GBT Technologies Inc. (OTC PINK: GTCH) ("GBT" or the "Company") started the development of its wearable version of its qTerm device. GBT's qTerm, is a human vitals device targeted to measure human vitals with a touch of a finger. GBT plans to design a wearable version of qTerm in a bracelet or watch form.
Wearable Health Devices are becoming increasingly popular over the past decade, assisting people to better monitor their health and activities. They are used for self-health monitoring, providing health related information that can help with earlier diagnostic and treatment. The technology is based on miniaturized sensors and electronics, that is enabling reliable and accurate wearable devices, assisting with health monitoring and potential detection of abnormalities. The qTerm wearable device plans to have the same features as the finger-touch version plus additional features that can be utilized due to its shape and size. The main wearable advantages are the capability to perform a background vitals check as part of its on-going health monitoring uses. Users will be able to initiate a check-per-demand at any time but the device is planned to conduct its own timely background checks based on user's health concerns and conditions. In this way even if users forget to take their daily vitals, the device will automatically do so for them, alerting of abnormalities. The device could be integrated with clinics and hospitals data systems to inform the health care system alerting physicians about concerns even during telemedicine sessions. The wearable device's hardware is planned to include optical sensors, Low Energy Bluetooth (BLE) radio, and an LCD display, Its plan is to be synchronized with qTerm's web portal and its mobile application. As with its finger-touch version, the data will be kept on a high security data center used by an AI program for analysis and on-going monitoring. GBT started to work on the device's architecture and plans to start its components design in Q1 2022.
"We started the design of qTerm's wearable version architecture and plan to start the system's components design in Q1 2022. As wearable health devices are constantly evolving, enabling continuous health monitoring of human vitals, we are taking this technology into a higher level, outfitting it with intelligent capabilities. One of its major planned key advantages is the capability to perform automatic background health measurements during a daily routine, relieving users from conducting on-demand checks, and in case of potential issue detection, the device will alert the user including his/her clinic or physician. This type of feature can be incredibly useful for users that forget to take their vitals at certain times, not aware of a potential health problem. The wearable version of qTerm is planned to be equipped with the same intelligent system to perform on-going health analytics and monitoring. Technically, the wearable device will include similar sensors with radio and mobile technologies, same as the finger version. It could be easily connected to hospitals or clinics data centers, sending the results to a physician's office during telemedicine sessions. qTerm wearable version will include a web widget and synchronized mobile application. We are now architecting the system's main components and its data structure. The device is based on multiple advanced technologies, among them are biomedical electronics, with radio software and data science. We envision our qTerm wearable device as an integral part of our personal health watching process, a concept with the purpose of positioning individuals within our healthcare system, managing their own health, working together with care providers to ensure a healthy lifestyle." Said Danny Rittman the Company's CTO.
There is no guarantee that the Company will be successful in researching, developing or implementing this system. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.
GBT Technologies, Inc. (OTC PINK: GTCH) ("GBT") (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT's mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT's goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT's vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.
Certain statements contained in this press release may constitute "forward-looking statements". Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements because of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.
Dr. Danny Rittman, CTO
More info on GTCH at Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/Get News Alerts on GBT Technologies Inc. (GTCH)
Like Tech Stocks? View our Tech Stocks Directory